Rhythm Pharmaceuticals, Inc.
RYTM· Nasdaq
Released Nov 2, 2020, during market hours
10-Q filed Nov 2, 2020, 33 days after period end · 0001558370-20-012208
| Metric | Q3 2020 | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|---|
| Net Income | -$33.82M | -$36.00M | -$17.69M | -$10.02M |
| EPS Diluted | -$0.77 | -$1.04 | -$0.52 | -$1.78 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rhythm Pharmaceuticals, Inc. · CIK 1649904 · Engraved from SEC EDGAR